Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$108.23
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Itron Analyst Ratings and Price Targets | NASDAQ:ITRI | Benzinga
Itron Inc has a consensus price target of $102.53 based on the ratings of 18 analysts. The high is $136 issued by TD Cowen on November 1, 2024. The low is $50 issued by Morgan Stanley on November 4, 2022. The 3 most-recent analyst ratings were released by Guggenheim, Piper Sandler, and Canaccord Genuity on February 27, 2025, February 27, 2025, and February 26, 2025, respectively. With an average price target of $129.67 between Guggenheim, Piper Sandler, and Canaccord Genuity, there's an implied 19.81% upside for Itron Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Guggenheim
Piper Sandler
Canaccord Genuity
Oppenheimer
TD Cowen
1calculated from analyst ratings
Analyst Ratings for Itron
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/27/2025 | Buy Now | 22.89% | Guggenheim | Joseph Osha77% | $135 → $133 | Maintains | Buy | Get Alert |
| 02/27/2025 | Buy Now | 14.57% | Piper Sandler | Kashy Harrison41% | $119 → $124 | Maintains | Neutral | Get Alert |
| 02/26/2025 | Buy Now | 21.96% | Canaccord Genuity | Austin Moeller37% | $130 → $132 | Maintains | Buy | Get Alert |
| 02/26/2025 | Buy Now | 21.04% | Oppenheimer | Noah Kaye75% | $124 → $131 | Maintains | Outperform | Get Alert |
| 11/06/2024 | Buy Now | 24.73% | Guggenheim | Joseph Osha77% | $128 → $135 | Maintains | Buy | Get Alert |
| 11/01/2024 | Buy Now | 25.66% | TD Cowen | Jeffrey Osborne31% | $125 → $136 | Maintains | Buy | Get Alert |
| 11/01/2024 | Buy Now | 20.11% | Roth MKM | Chip Moore61% | $125 → $130 | Maintains | Buy | Get Alert |
| 11/01/2024 | Buy Now | 9.95% | Piper Sandler | Kashy Harrison41% | $110 → $119 | Maintains | Neutral | Get Alert |
| 11/01/2024 | Buy Now | 14.57% | Oppenheimer | Noah Kaye75% | $120 → $124 | Maintains | Outperform | Get Alert |
| 11/01/2024 | Buy Now | 21.96% | Baird | Ben Kallo61% | $123 → $132 | Maintains | Outperform | Get Alert |
| 09/27/2024 | Buy Now | 21.04% | Janney Montgomery Scott | Sean Milligan35% | → $131 | Initiates | → Buy | Get Alert |
| 08/21/2024 | Buy Now | 15.49% | Roth MKM | Chip Moore61% | $125 → $125 | Maintains | Buy | Get Alert |
| 08/05/2024 | Buy Now | 1.64% | Stephens & Co. | Tommy Moll72% | $110 → $110 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/02/2024 | Buy Now | 15.49% | Roth MKM | Chip Moore61% | $122 → $125 | Maintains | Buy | Get Alert |
| 08/02/2024 | Buy Now | 13.65% | Baird | Ben Kallo61% | $115 → $123 | Maintains | Outperform | Get Alert |
| 07/22/2024 | Buy Now | 1.64% | Piper Sandler | Kashy Harrison41% | $109 → $110 | Maintains | Neutral | Get Alert |
| 07/17/2024 | Buy Now | 3.48% | Oppenheimer | Noah Kaye75% | $110 → $112 | Maintains | Outperform | Get Alert |
| 07/16/2024 | Buy Now | 3.48% | JP Morgan | Mark Strouse59% | $104 → $112 | Maintains | Neutral | Get Alert |
| 07/16/2024 | Buy Now | 12.72% | Roth MKM | Chip Moore61% | $112 → $122 | Maintains | Buy | Get Alert |
| 07/11/2024 | Buy Now | 20.11% | Guggenheim | Joseph Osha77% | → $130 | Upgrade | Neutral → Buy | Get Alert |
| 06/20/2024 | Buy Now | 10.87% | Canaccord Genuity | Austin Moeller37% | $115 → $120 | Maintains | Buy | Get Alert |
| 05/21/2024 | Buy Now | 0.71% | Piper Sandler | Kashy Harrison41% | $109 → $109 | Downgrade | Overweight → Neutral | Get Alert |
| 05/06/2024 | Buy Now | 1.64% | Stephens & Co. | Tommy Moll72% | $85 → $110 | Maintains | Equal-Weight | Get Alert |
| 05/03/2024 | Buy Now | 6.26% | Canaccord Genuity | Austin Moeller37% | $105 → $115 | Maintains | Buy | Get Alert |
| 05/03/2024 | Buy Now | 6.26% | TD Cowen | Jeffrey Osborne31% | $110 → $115 | Maintains | Buy | Get Alert |
| 05/03/2024 | Buy Now | 3.48% | Roth MKM | Chip Moore61% | $102 → $112 | Maintains | Buy | Get Alert |
| 05/03/2024 | Buy Now | 0.71% | Piper Sandler | Kashy Harrison41% | $103 → $109 | Reiterates | Overweight → Overweight | Get Alert |
| 05/03/2024 | Buy Now | 1.64% | Oppenheimer | Noah Kaye75% | $100 → $110 | Maintains | Outperform | Get Alert |
| 04/23/2024 | Buy Now | -5.76% | Roth MKM | Chip Moore61% | → $102 | Maintains | Buy | Get Alert |
| 04/11/2024 | Buy Now | -4.83% | Piper Sandler | Kashy Harrison41% | $105 → $103 | Maintains | Overweight | Get Alert |
| 03/13/2024 | Buy Now | 1.64% | TD Cowen | Jeffrey Osborne31% | $107 → $110 | Maintains | Outperform | Get Alert |
| 03/13/2024 | Buy Now | 6.26% | Baird | Ben Kallo61% | $108 → $115 | Maintains | Outperform | Get Alert |
| 03/13/2024 | Buy Now | -15% | JP Morgan | Mark Strouse59% | $77 → $92 | Maintains | Neutral | Get Alert |
| 02/27/2024 | Buy Now | -2.98% | Piper Sandler | Kashy Harrison41% | $91 → $105 | Maintains | Overweight | Get Alert |
| 02/27/2024 | Buy Now | -0.21% | Baird | Ben Kallo61% | $68 → $108 | Upgrade | Neutral → Outperform | Get Alert |
| 01/19/2024 | Buy Now | -25.16% | Oppenheimer | Noah Kaye75% | → $81 | Upgrade | Perform → Outperform | Get Alert |
| 01/04/2024 | Buy Now | — | Raymond James | Pavel Molchanov52% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 12/19/2023 | Buy Now | -15.92% | Piper Sandler | Kashy Harrison41% | $72 → $91 | Upgrade | Neutral → Overweight | Get Alert |
| 12/12/2023 | Buy Now | -37.17% | JP Morgan | Paul Coster68% | → $68 | Upgrade | Underweight → Neutral | Get Alert |
| 12/05/2023 | Buy Now | -24.24% | Roth MKM | Chip Moore61% | → $82 | Initiates | → Buy | Get Alert |
| 12/01/2023 | Buy Now | -37.17% | Canaccord Genuity | Austin Moeller37% | → $68 | Initiates | → Hold | Get Alert |
| 11/03/2023 | Buy Now | -33.48% | Piper Sandler | Kashy Harrison41% | $71 → $72 | Maintains | Neutral | Get Alert |
| 10/19/2023 | Buy Now | -39.94% | JP Morgan | Paul Coster68% | $72 → $65 | Maintains | Underweight | Get Alert |
| 10/06/2023 | Buy Now | -34.4% | Piper Sandler | Kashy Harrison41% | $63 → $71 | Maintains | Neutral | Get Alert |
| 09/22/2023 | Buy Now | -26.08% | Seaport Global | Scott Graham74% | → $80 | Initiates | → Buy | Get Alert |
| 09/11/2023 | Buy Now | — | Guggenheim | Joseph Osha77% | — | Initiates | → Neutral | Get Alert |
| 08/18/2023 | Buy Now | -24.24% | Argus Research | John Eade74% | → $82 | Upgrade | Hold → Buy | Get Alert |
| 08/04/2023 | Buy Now | -12.22% | TD Cowen | Jeffrey Osborne31% | $85 → $95 | Maintains | Outperform | Get Alert |
| 08/04/2023 | Buy Now | -30.7% | Baird | Ben Kallo61% | $63 → $75 | Maintains | Neutral | Get Alert |
| 07/12/2023 | Buy Now | — | Raymond James | Pavel Molchanov52% | — | Downgrade | Strong Buy → Outperform | Get Alert |
| 05/08/2023 | Buy Now | -41.79% | Piper Sandler | Kashy Harrison41% | $58 → $63 | Maintains | Neutral | Get Alert |
| 05/05/2023 | Buy Now | -35.32% | EF Hutton | Chip Moore61% | $60 → $70 | Maintains | Buy | Get Alert |
| 05/05/2023 | Buy Now | -41.79% | Baird | Ben Kallo61% | $52 → $63 | Maintains | Neutral | Get Alert |
| 05/05/2023 | Buy Now | -35.32% | Raymond James | Pavel Molchanov52% | $60 → $70 | Maintains | Strong Buy | Get Alert |
| 03/03/2023 | Buy Now | -53.8% | JP Morgan | Paul Coster68% | $53 → $50 | Downgrade | Neutral → Underweight | Get Alert |
| 02/28/2023 | Buy Now | -58.42% | Stephens & Co. | Tommy Moll72% | → $45 | Reiterates | → Equal-Weight | Get Alert |
| 02/28/2023 | Buy Now | -46.41% | Piper Sandler | Kashy Harrison41% | $48 → $58 | Maintains | Neutral | Get Alert |
| 02/28/2023 | Buy Now | -51.95% | Baird | Ben Kallo61% | $40 → $52 | Maintains | Neutral | Get Alert |
| 02/28/2023 | Buy Now | -44.56% | EF Hutton | Chip Moore61% | → $60 | Reiterates | → Buy | Get Alert |
| 02/28/2023 | Buy Now | -44.56% | Raymond James | Pavel Molchanov52% | $57 → $60 | Maintains | Strong Buy | Get Alert |
| 02/02/2023 | Buy Now | -33.48% | Cowen & Co. | Jeffrey Osborne31% | $55 → $72 | Maintains | Outperform | Get Alert |
| 11/04/2022 | Buy Now | -53.8% | Morgan Stanley | Connor Lynagh57% | $55 → $50 | Maintains | Equal-Weight | Get Alert |
| 11/04/2022 | Buy Now | -44.56% | EF Hutton | Chip Moore61% | $72 → $60 | Maintains | Buy | Get Alert |
| 11/04/2022 | Buy Now | -47.33% | Raymond James | Pavel Molchanov52% | $68 → $57 | Maintains | Strong Buy | Get Alert |
| 10/20/2022 | Buy Now | -46.41% | JP Morgan | Mark Strouse59% | $65 → $58 | Maintains | Neutral | Get Alert |
| 08/08/2022 | Buy Now | — | JP Morgan | Paul Coster68% | — | Downgrade | Overweight → Neutral | Get Alert |
| 08/05/2022 | Buy Now | -49.18% | Stephens & Co. | Tommy Moll72% | $65 → $55 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/20/2022 | Buy Now | -32.55% | JP Morgan | Mark Strouse59% | $71 → $73 | Maintains | Overweight | Get Alert |
| 07/19/2022 | Buy Now | -53.8% | Piper Sandler | Pearce Hammond34% | $51 → $50 | Maintains | Neutral | Get Alert |
| 07/12/2022 | Buy Now | -37.17% | Raymond James | Pavel Molchanov52% | $72 → $68 | Maintains | Strong Buy | Get Alert |
| 06/09/2022 | Buy Now | -49.18% | Morgan Stanley | Connor Lynagh57% | $60 → $55 | Maintains | Equal-Weight | Get Alert |
| 05/03/2022 | Buy Now | -22.39% | EF Hutton | Chip Moore61% | $92 → $84 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Itron (ITRI) stock?
The latest price target for Itron (NASDAQ:ITRI) was reported by Guggenheim on February 27, 2025. The analyst firm set a price target for $133.00 expecting ITRI to rise to within 12 months (a possible 22.89% upside). 30 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Itron (ITRI)?
The latest analyst rating for Itron (NASDAQ:ITRI) was provided by Guggenheim, and Itron maintained their buy rating.
When was the last upgrade for Itron (ITRI)?
The last upgrade for Itron Inc happened on July 11, 2024 when Guggenheim raised their price target to $130. Guggenheim previously had a neutral for Itron Inc.
When was the last downgrade for Itron (ITRI)?
The last downgrade for Itron Inc happened on May 21, 2024 when Piper Sandler changed their price target from $109 to $109 for Itron Inc.
When is the next analyst rating going to be posted or updated for Itron (ITRI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Itron, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Itron was filed on February 27, 2025 so you should expect the next rating to be made available sometime around February 27, 2026.
Is the Analyst Rating Itron (ITRI) correct?
While ratings are subjective and will change, the latest Itron (ITRI) rating was a maintained with a price target of $135.00 to $133.00. The current price Itron (ITRI) is trading at is $108.23, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.